Skip to main content
Fig. 5 | BMC Neurology

Fig. 5

From: Lymphoproliferative disorder during temozolomide therapy; a representative case of a formidable complication and management challenges

Fig. 5

OIIA-LPD is characterized by its association with immunosuppression, and regression after cessation of immunosuppressive agents. OIIA-LPD is occasionally associated with EBV infection, albeit not necessarily. This entity ranges from non-neoplastic lymphoid proliferation to malignant lymphoma (A). OIIA-LPD is mainly defined by its clinical pictures, whereas malignant lymphoma is predominantly defined pathologically and biologically (B)

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us